Valproic acid, congenital malformation risk advance, and relation of the 13th pregnancy half year

| コメント(0) | トラックバック(0)
Valproic acid, congenital malformation risk advance, and relation of the 13th pregnancy half year
Source on June 14, 2010: NEJM (thesis list) category: Nerve internal disease (related paper) - obstetrics and gynecology trouble (related paper) and - problem (related paper) document related to administering: Jentink J et al. Valproic Acid Monotherapy in Pregnancy and Major Congenital Malformations. NEJM. 2010;362:2185-2193

The relation to the congenital malformation of 14 specified from the valproic acid use and eight cohort studies at the 13th pregnancy half year is discussed by the case contrast research by using the data base of the antiepileptic research of Europe. A significant relation was seen about congenital malformations (spina bifida, atrial septal defect, uvula bifida, hypospadia, polydactyly, and craniosynostosis)14 inside 6 in the valproic acid monotherapy and the risk advance.

Japan is good country!
http://japan-power.net/
PLEASE come here!

トラックバック(0)

トラックバックURL: http://www.japan-power.net/mt/mt-tb.cgi/1786

コメントする

カテゴリ

ウェブページ

Powered by Movable Type 4.23-ja

このブログ記事について

このページは、jp_masterがJune 19, 2010 11:16 PMに書いたブログ記事です。

ひとつ前のブログ記事は「The source for bread Demick (H1N1), 2009, and 15 days June, the lapse and 2010 the Hong Kong survey similar to the seasonality influenza A」です。

次のブログ記事は「Yokohama City University medical center suicide prevention"Formulation care Shite of medicine"」です。

最近のコンテンツはインデックスページで見られます。過去に書かれたものはアーカイブのページで見られます。